SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Liu Shuwen)
 

Search: WFRF:(Liu Shuwen) > Expression and clin...

Expression and clinical significance of FXYD3 in endometrial cancer

Li, Yifei (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Zhang, Xia (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Xu, Shuwen (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
show more...
Ge, Jing (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Liu, Jing (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Li, Lin (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Fang, Guiying (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Meng, Yali (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Zhang, Hongzhen (author)
First Hospital of Hebei Medical University, Shijiazhuang, China
Sun, Xiao-Feng (author)
Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Onkologiska kliniken US
show less...
 (creator_code:org_t)
2014-05-23
2014
English.
In: Oncology Letters. - : Spandidos Publications. - 1792-1074 .- 1792-1082. ; 8:2, s. 517-522
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • FXYD3 expression is upregulated in numerous cancer cell types. The present study compared the FXDY3 expression in normal endometrium, premalignant lesion and endometrial cancer tissue samples, and investigated the correlation between FXDY3 expression and clinicopathological features. FXYD3 expression was analyzed by streptavidin-peroxidase immunohistochemistry in 21 normal endometrial tissue samples, 18 atypical endometrial hyperplasia samples and 50 tissues obtained from patients diagnosed with endometrial cancer. The percentage of FXYD3-positive cell expression in the normal endometrium, atypical hyperplasia and endometrial cancer tissues samples was 0, 22, and 26%, respectively. The differences between the atypical hyperplasia and endometrial cancer groups were statistically significant when compared with the normal group (P=0.007 and P=0.037, respectively). There was no significant difference between the atypical hyperplasia and endometrial cancer groups. The percentage of FXYD3-positive cells correlated with the fertility frequency (Pless than0.05). In conclusion, FXYD3 is a potential biomarker for endometrial cancer, and its upregulation may be an early event in endometrial carcinoma progression. In addition, FXYD3 expression in endometrial carcinoma correlates with fertility frequency.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

FXYD3; endometrial hyperplasia; endometrial neoplasm; immunohistochemistry

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view